Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genotypic prognostic markers.

S Stilgenbauer1, H Döhner

  • 1Department of Internal Medicine III, University of Ulm, Germany. stephan.stilgenbauer@medizin.uni-ulm.de

Current Topics in Microbiology and Immunology
|December 6, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of steroid-refractory acute/chronic graft versus host disease: A single-center real-world experience of ruxolitinib in combination with extracorporeal photopheresis in a high-risk population.

Leukemia research·2024
Same author

Disseminated fusariosis after allogenic hematopoietic stem cell transplantation: case report.

Infection·2024
Same author

Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia.

Scientific reports·2023
Same author

The German Network for Personalized Medicine to enhance patient care and translational research.

Nature medicine·2023
Same author

Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling.

Blood·2020
Same author

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.

Leukemia·2020
Same journal

Resolution Biology in Soft Tissue Joint Disease.

Current topics in microbiology and immunology·2026
Same journal

A 25+ Year Journey on Yeast-Regulated Cell Death Research.

Current topics in microbiology and immunology·2026
Same journal

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026
Same journal

Resolution Pharmacology Targeting the Melanocortin System.

Current topics in microbiology and immunology·2026
Same journal

Resolution of Skeletal Muscle Inflammation: Role of Specialized Pro-resolving Lipid Mediators in the Recovery from Exercise, Injury, and Disease.

Current topics in microbiology and immunology·2026
Same journal

Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Strains.

Current topics in microbiology and immunology·2026
See all related articles

Genetic markers in chronic lymphocytic leukemia (CLL) significantly improve prognostic accuracy. Analyzing genomic aberrations and immunoglobulin heavy chain (VH) mutation status allows for early, individualized risk assessment in CLL patients.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Chronic lymphocytic leukemia (CLL) is characterized by genomic aberrations in over 80% of cases.
  • Key genes like ATM and p53 are implicated in CLL pathogenesis via specific deletions (11q and 17p).
  • Immunoglobulin heavy chain (VH) gene mutation status is a critical prognostic factor, dividing patients into distinct survival groups.

Purpose of the Study:

  • To elucidate the role of genetic analyses in understanding CLL pathogenesis and prognosis.
  • To correlate specific genomic aberrations and VH mutation status with clinical features and patient outcomes.
  • To establish the independent prognostic value of these genetic markers for early risk stratification.

Main Methods:

  • Genomic analysis using fluorescence in situ hybridization (FISH) and DNA sequencing.

Related Experiment Videos

  • Assessment of VH gene mutation status.
  • Multivariate analysis to determine independent prognostic value.

    • Main Results:

    • 11q deletion is linked to lymphadenopathy and rapid progression.
    • 17p deletion predicts treatment failure and short survival.
    • Mutated VH genes correlate with longer survival, while unmutated VH genes indicate shorter survival.
    • VH mutation status and genomic abnormalities show independent prognostic value, irrespective of clinical stage.

    Conclusions:

    • Genetic markers, including genomic aberrations and VH mutation status, are crucial for understanding CLL.
    • These markers enable accurate outcome prediction and early risk assessment for individual CLL patients.
    • This facilitates personalized treatment strategies and improved patient management.